InvestRight - Short Term Trading St Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : InvestRight - Short Term Trading St

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: KLH who wrote (439)	10/20/1998 11:05:00 AM
From: Jeffrey L. Henken	of 939

I see absolutely no reason, given the current market conditions and the recover in the biotech group as a whole, that a buy here would not be a wise move. Biotech stocks have cost unwary investors a lot of money over the years but they do have a tendency to move as a group. The current move is upward. I would not hesitate to commit some funds here if you have some available cash but not too much. I would not make biotechs too large a portion of a stock portfolio. Since you are in TIE, I think you would agree. Take a look at Cortex pharmacueticals (CORX) as an example of the risks involved. The nice thing about GENZL is they have plenty of cash and are already manufacturing and selling product. Here are URLs for those that want to look at the risk and rewards of investing in biotechs based on these two examples: quote.yahoo.com Regards, Jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next